EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

MIRA: Myocardial insulin resistance app for clinical practice

Queralt Martín-Saladich, Rafael Simó, José Raul Herance, Miguel A González Ballester

Computer Methods and Programs in Biomedicine · 2025

DOI: 10.1016/j.cmpb.2025.108674 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Computer Methods and Programs in Biomedicine, 2025. Verfasst von Queralt Martín-Saladich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Molecular Imaging Research Group, Vall d'Hebron Research Institute (VHIR), Nuclear Medicine, Radiology and Cardiology Departments, Vall d'Heb…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Myocardium. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Type 2 diabetes (T2D) is a prevalent disease characterized by insulin resistance (IR), leading to energy disruptions in myocardial cells and increasing cardiovascular (CV) risk. Current diagnostic methods are either systemic, thus lacking tissue-specific information, or invasive. The hyperinsulinemic euglycemic clamp (HEC) combined with [18F]FDG-PET images, only used in clinical trials, allow to assess regional IR and identify phenotypes within T2D, linking myocardial IR to higher CV risk. However, phenotyping is not easily accessible, creating a need for alternative assessment tools. Thus, we propose a myocardial IR model to address these gaps and improve T2D management. METHODS: The study included forty-two patients with T2D who enrolled in a clinical trial (NCT02248311) and who underwent biochemical analyses, anthropometric measurements and [18F]FDG PET/CT imaging before and after HEC with. Patients were phenotyped into mIR and mIS according to poor or good uptake after HEC, respectively. The proposed predictive model was based on stepwise regression including feature selection to provide an estimate of myocardial IS and thus IR=1/IS by using biochemical parameters in T2D. A software application, the myocardial IR app (MIRA), was developed using MATLAB. RESULTS: MIRA was developed as a myocardial IR estimator (R2=0.97, p=7.1 × 10-7, error=1.24) for patients with T2D. Moreover, since HEC is not allowed in rutinary clinical practice, the application includes a prediction of the expected myocardial HEC [18F]FDG uptake from baseline uptake (r=0.52, p=5 × 10-4, R2=0.60). The app also yields the patient's phenotype, either mIR or mIS, according to poor or good uptake after HEC. Enhanced CV risk exposure due to altered T2D biomarkers and associated to mIR is also provided with highlighted features. CONCLUSIONS: We hereby present MIRA, a myocardial IR calculation app to manage myocardial-specific affectation in T2D, as well as to provide with patient phenotyping and CV risk assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceMyocardiumAgedFemaleHumansMaleMiddle AgedFluorodeoxyglucose F18Glucose Clamp TechniquePositron Emission Tomography Computed TomographySoftware

Stichwörter der Autor:innen

Biomedical ModellingCardiovascular riskInsulin ResistanceType 2 Diabetes[(18)F]FDG-PET

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Medical Molecular Imaging Research Group, Vall d'Hebron Research Institute (VHIR), Nuclear Medicine, Radiology and Cardiology Departments, Vall d'Hebron University Hospital, Autonomous University Barcelona, Barcelona 08…
  • Diabetes and Metabolism Research Group, VHIR, Endocrinology Department, Vall d'Hebron University Hospital, Autonomous University Barcelona, Barcelona 08035, Spain; CIBERDEM (Instituto de Salud Carlos III), Madrid 28029,…
  • BCN Medtech, Department of Engineering, Universitat Pompeu Fabra, Barcelona 08018, Spain; Catalan Institution for Research and Advanced Studies ICREA, 08010 Barcelona, Spain. Electronic address: ma.gonzalez@upf.edu.

Förderung

  • Carlos III Health Institute

Zitieren

APA

Martín-Saladich, Q., Simó, R., Herance, J. R., & Ballester, M. A. G. (2025). MIRA: Myocardial insulin resistance app for clinical practice. Computer Methods and Programs in Biomedicine. https://doi.org/10.1016/j.cmpb.2025.108674

Vancouver

Martín-Saladich Q, Simó R, Herance JR, Ballester MAG. MIRA: Myocardial insulin resistance app for clinical practice. Computer Methods and Programs in Biomedicine. 2025. doi:10.1016/j.cmpb.2025.108674

BibTeX
@article{MartnSaladich2025,
  author = {Martín-Saladich, Queralt and Simó, Rafael and Herance, José Raul and Ballester, Miguel A González},
  title = {MIRA: Myocardial insulin resistance app for clinical practice},
  journal = {Computer Methods and Programs in Biomedicine},
  year = {2025},
  doi = {10.1016/j.cmpb.2025.108674}
}
Kostenlos starten →